HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey C Gildersleeve Selected Research

Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)

10/2015Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.
1/2013Sugar-binding proteins from fish: selection of high affinity "lambodies" that recognize biomedically relevant glycans.
1/2013Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.
3/2010Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey C Gildersleeve Research Topics

Disease

26Neoplasms (Cancer)
11/2021 - 08/2007
6Infections
01/2022 - 01/2013
5Prostatic Neoplasms (Prostate Cancer)
01/2017 - 04/2009
3Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2014
3Carcinoma (Carcinomatosis)
03/2011 - 12/2005
2HIV Infections (HIV Infection)
10/2017 - 01/2013
2Colonic Neoplasms (Colon Cancer)
01/2014 - 08/2010
1Communicable Diseases (Infectious Diseases)
01/2021
1Guillain-Barre Syndrome
01/2021
1Disease Progression
10/2020
1Nervous System Diseases (Neurological Disorders)
10/2020
1COVID-19
10/2020
1Adenocarcinoma
01/2019
1Cholera
01/2018
1Diarrhea
01/2018
1Melanoma (Melanoma, Malignant)
01/2017
1Leukemia
01/2013
1Acquired Immunodeficiency Syndrome (AIDS)
01/2013
1Ovarian Neoplasms (Ovarian Cancer)
03/2011
1Stomach Diseases
08/2010
1Opportunistic Infections (Opportunistic Infection)
07/2010
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2010
1Lymphatic Metastasis
01/2010
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2010

Drug/Important Bio-Agent (IBA)

16AntibodiesIBA
01/2021 - 08/2007
14Polysaccharides (Glycans)IBA
01/2021 - 08/2007
12CarbohydratesIBA
11/2021 - 12/2005
12AntigensIBA
11/2021 - 12/2005
9Tn antigenIBA
01/2017 - 12/2005
5Immunoglobulin M (IgM)IBA
10/2020 - 01/2013
5Immunoglobulin G (IgG)IBA
10/2020 - 01/2013
5Monoclonal AntibodiesIBA
01/2019 - 07/2009
5Blood Group Antigens (Blood Groups)IBA
01/2018 - 08/2007
5VaccinesIBA
10/2015 - 04/2009
4Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2010
4Cancer VaccinesIBA
11/2021 - 03/2013
4LectinsIBA
01/2017 - 07/2009
4Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA
10/2015 - 03/2010
4Biomarkers (Surrogate Marker)IBA
01/2014 - 04/2009
3ABO Blood-Group SystemIBA
01/2021 - 08/2010
3PROSTVACIBA
01/2017 - 03/2013
2GD2 gangliosideIBA
11/2021 - 01/2017
2MucinsIBA
01/2019 - 10/2012
2EpitopesIBA
01/2019 - 03/2011
2Glycoproteins (Glycoprotein)IBA
01/2014 - 08/2007
1Type V Secretion SystemsIBA
01/2022
1AcidsIBA
11/2021
1acetamideIBA
11/2021
1IsoantibodiesIBA
01/2021
1Sialyl Lewis X AntigenIBA
10/2020
1GangliosidesIBA
10/2020
1COVID-19 VaccinesIBA
10/2020
1GlycopeptidesIBA
01/2019
1Broadly Neutralizing AntibodiesIBA
10/2017
1Methylcellulose (BFL)IBA
01/2017
1blood group A trisaccharideIBA
01/2017
1Cytostatic AgentsIBA
01/2017
1FetuinsIBA
12/2016
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2016
1Serine (L-Serine)FDA Link
05/2016
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
01/2014
1Thomsen-Friedenreich antigenIBA
08/2013
1AIDS VaccinesIBA
01/2013
1AcetylgalactosamineIBA
10/2012
1EnzymesIBA
03/2011
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2011
1H antigenIBA
08/2010
1keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
03/2010
1Vaccine AdjuvantsIBA
03/2010
1Carrier Proteins (Binding Protein)IBA
03/2010
1HaptensIBA
03/2010
1N- acetylgalactosaminyl- alpha(1- 3)galactoseIBA
01/2010
1Helix lectinIBA
07/2009
1soybean lectinIBA
07/2009
1Vicia lectinsIBA
07/2009
1Lewis Blood Group AntigensIBA
08/2007

Therapy/Procedure

4Immunotherapy
01/2019 - 01/2013
1Blood Transfusion (Blood Transfusions)
01/2021
1Therapeutics
01/2017